FOCL
EDAP TMS S.A.
4.20$
-1.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.4% | -12.3% | -20.1% | -14.8% | -16.5% | -3.3% | -0.6% | -10.4% | -3.8% | 4.1% | 3.4% | -8.6% | 0.4% | 8.5% | 4.7% | 10.1% | -5.5% | -24.3% | -21.2% | -23.3% | |
| 6.2% | 5.5% | 5.7% | 4.5% | 4.2% | 6.3% | 3.6% | 4.9% | 3.4% | 3.1% | 2.9% | 4.4% | 3.8% | 4.6% | 5.3% | 4.4% | 3.0% | 3.2% | 4.0% | 4.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 3.9% | 11.6% | 5.1% | 3.6% | |
| -2.1% | -1.9% | -12.5% | -3.9% | 3.0% | -3.1% | 7.2% | 3.1% | -0.3% | -0.2% | -0.6% | -4.7% | -3.2% | 0.0% | -0.3% | 1.2% | -7.8% | -4.8% | -3.1% | 4.2% | |
| 7.4% | 11.1% | 4.6% | 2.8% | 2.6% | 3.9% | 2.3% | 3.2% | 3.8% | 0.5% | 0.9% | 1.8% | 1.5% | 0.9% | 1.3% | 0.9% | 1.1% | 2.0% | 2.1% | 7.0% | |
| -8.1% | -5.6% | -3.1% | 1.6% | -3.0% | -2.7% | 0.9% | -2.4% | -3.9% | -1.7% | -1.1% | -5.7% | -4.0% | -3.4% | -4.8% | -3.7% | -4.3% | -7.2% | -6.4% | -8.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -1.7% | -2.0% | 7.1% | 12.2% | |
| 25.7% | 53.2% | 1.3% | 4.0% | 2.8% | -1.5% | 5.2% | 8.0% | 22.5% | 6.2% | 21.4% | 8.0% | 3.0% | -1.5% | 7.7% | 46.0% | 39.5% | -1.5% | 7.2% | 12.2% | |
| 51.1% | 41.1% | -19.1% | -7.5% | -22.0% | -11.3% | 8.7% | -0.2% | 12.0% | 3.5% | 21.4% | 2.1% | -3.8% | 2.4% | 14.3% | 45.0% | 23.7% | -29.6% | -24.7% | -14.8% | |
| -16.8% | -23.4% | -24.7% | -17.6% | -19.0% | -7.2% | -3.0% | -13.5% | -7.5% | 3.7% | 2.5% | -10.3% | -1.1% | 7.6% | 3.5% | 9.2% | -6.6% | -26.2% | -23.2% | -30.3% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.